Marshall University is a public research university in Huntington, West Virginia. It was founded in 1837 and is named after John Marshall, the fourth Chief Justice of the United States.

During the past decade, Marshall University conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshall University" #1 sponsor was "Marshall University" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Global Kinetics Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshall University" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator and "Pediatric Eye Disease Investigator Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marshall University" are "Amblyopia" (1 trials), "Burnout" (1 trials), "Childhood Obesity" (1 trials), "Compassion Fatigue" (1 trials) and "Degenerative Spondylolisthesis" (1 trials). Many other conditions were trialed in "Marshall University" in a lesser frequency.

Most popular intervention types in "Marshall University" are "Drug" (5 trials), "Device" (3 trials), "Behavioral" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "6 minutes activity" (1 trials), "ASA 100 mg" (1 trials), "Erenumab 140mg" (1 trials), "Erenumab 70 mg" (1 trials) and "Mindfulness-Based Resilience Training" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marshall University" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Marshall University". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Marshall University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marshall University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Marshall University has several departments that took part in Clinical trials: "Marshall University Department of Clinical Research" - 6 trials